当前位置: X-MOL 学术Clin. Pharmacokinet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
Clinical Pharmacokinetics ( IF 4.5 ) Pub Date : 2020-05-25 , DOI: 10.1007/s40262-020-00897-9
Xiaomei I Liu 1 , Jeremiah D Momper 2 , Natella Y Rakhmanina 1, 3 , Dionna J Green 4 , Gilbert J Burckart 5 , Tim R Cressey 6, 7, 8 , Mark Mirochnick 9 , Brookie M Best 2 , John N van den Anker 1, 10 , André Dallmann 10, 11
Affiliation  

Background

Predicting drug pharmacokinetics in pregnant women including placental drug transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral drugs, dolutegravir and raltegravir.



中文翻译:

使用基于生理学的药代动力学模型预测 Dolutegravir 和 Raltegravir 的母体和胎儿药代动力学。

背景

预测包括胎盘药物转移在内的孕妇的药物药代动力学仍然具有挑战性。本研究旨在开发和评估基于母胎生理学的两种抗逆转录病毒药物 dolutegravir 和 raltegravir 的药代动力学模型。

更新日期:2020-05-25
down
wechat
bug